Examining medicine shortages and their consequences through economic, clinical, and economic lens
A study on medicine shortages in the Netherlands found that disease and costs were the two most affected elements, with 30% and 20% of shortages rated high on these elements, respectively. The study used a framework of economic, clinical, and patient outcomes to assess the impact of medicine shortages on patients. Direct impact, represented by alternative product and disease, was rated high for 30% of the shortages, while indirect impact, represented by costs, susceptibility, and number of patients, was rated high for 17% of the shortages. No significant differences in impact scores were found based on product characteristics.
Recent Posts
Strengthening Medicine Shortages Management for Enhanced Availability and Access
The European Medicines Agency made medicine shortages management a foundational policy objective in 2025, as highlighted in its annual reports and work programmes. By advancing coordinated shortages oversight and d...
AI Healthcare Liability and Ethical Accountability in Clinical Practice
AI Healthcare Liability has surged to the forefront of European healthcare as powerful clinical algorithms outpace existing legal structures. A joint opinion by the national bio...
Regulatory Expansion of OTC Glucose Monitoring for Children
The FDA has cleared the first over-the-counter continuous glucose monitor for children as young as two who do not use insulin, establishing OTC Glucose Monitoring Children as a practical new option for families. This